Lars Fruergaard Jorgensen to step down as CEO of Novo Nordisk Ruchika Sharma18 May 2025 5:15 AMDenmark: Novo Nordisk has announced that Lars Fruergaard Jorgensen will step down from his role as CEO of Novo Nordisk. He will continue as CEO...
Novo Nordisk application for oral Wegovy accepted by USFDA for weight loss Ruchika Sharma3 May 2025 9:51 AMPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for an...
Novo Nordisk promotes Rishang Deoras to Global Director - Diabetes Commercial Unit Ruchika Sharma17 April 2025 12:00 PMNovo Nordisk has promoted Rishang Deoras to Global Director - Diabetes Commercial Unit.Deoras shared the news in a LinkedIn post,...
Novo Nordisk reshapes Executive management team Ruchika Sharma4 April 2025 6:00 AM Novo Nordisk HA has announced that Camilla Sylvest has decided to leave the company after a distinguished career of 28 years with the Company,...
Novo Nordisk, The United Bio-Technology ink pact for 'triple G' obesity drug Ruchika Sharma25 March 2025 10:00 AMChina: Novo Nordisk and The United Laboratories International Holdings Limited (TUL)'s wholly-owned subsidiary The United Bio-Technology...
Novo Nordisk regains membership in UK pharma body Ruchika Sharma18 March 2025 10:00 AMLondon: Danish pharmaceutical giant Novo Nordisk has regained its membership in the UK's pharmaceutical industry body after serving a two-year...
CagriSema demonstrates superior weight loss in adults with obesity, type 2 diabetes in REDEFINE 2 trial: Novo Nordisk Ruchika Sharma14 March 2025 8:30 AMDenmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial, Novo...
Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular death in adults with type 2 diabetes, chronic kidney disease Ruchika Sharma29 Jan 2025 8:00 AMPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 11:31 AMPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Novo Nordisk bleeding disorder injection gets USFDA nod Ruchika Sharma21 Dec 2024 6:00 AMPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Alhemo (concizumab-mtci) injection as a...
Website unlawfully selling versions of Novo Nordisk weight loss drugs gets USFDA warning Ruchika Sharma3 July 2024 1:15 PMThe U.S. Food and Drug Administration (USFDA) said on tuesday it had issued a warning against a website called ozempen.com for illegally selling...
Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic Ruchika Sharma21 Jun 2024 10:26 AMShanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...
